Organ and Tissue Transplantation Market

Organ and Tissue Transplantation Market by Products (Tissue Products, Preservation Solution, and Immunosuppressive Drugs), by Applications (Organ Transplantation and Tissue Transplantation), by End-users (Hospitals, Transplant Centres, and Others), And By Regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa), Global Industry Analysis, Growth, Share, Size, Trends, And Forecast, 2021-2028

  • Report ID: HC-3957
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 184
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global organ and tissue transplantation sales market is expected to develop at a CAGR of 9.1% between 2020 and 2030, from an estimated USD 13.9 billion in 2020 to USD 27.9 billion in 2028.


Organ and Tissue Transplantation Market key takeaways

Organ failure is caused by a number of things, including poisoning, leukaemia, severe trauma, sepsis, blood loss, drug misuse, and other acute disorders. Diabetes and high blood pressure are the common causes of end-stage renal disease, which requires a kidney transplant or dialysis to keep a patient alive. The need for tissue and organ transplantation, particularly kidney, heart, liver, and lungs transplantation, is high around the world.

According to the US Department of Health and Human Services, there were around 122,913 people waiting for organ transplants in the US in 2019. Organ failure is caused by poor eating habits, excessive alcohol intake, and lack of exercise.

COVID-19 Impact:

  • Access to solid organ transplantation has been hampered by the COVID-19 pandemic. During the pandemic, the number of transplants performed in all countries decreased.
  • Highly afflicted organ transplants were kidneys, followed by the lungs, liver, and heart. COVID-19 had a global impact on transplantation, with a 31% decline in solid organ transplants conducted during the first wave of the pandemic as compared to the previous year.
  • Approximately 48,000 years of patient lives were lost as a result of this deterioration. Deceased donor transplants showed a 12 percent, 9 percent, 17 percent, and 5% drop, respectively, in kidney, liver, lung, and heart transplants.

Market Drivers, Restraints, and Opportunities:

Drivers: Increased occurrence of organ failure

  • Increased occurrence of organ failure and rising demand for transplant items such as tissue products, immunosuppressants, and organ preservation treatments are driving the global organ and tissue transplantation market.
  • Other factors driving the market include increasing incidence of acute diseases such as diabetes and high blood pressure that lead to end-stage renal disease, technological advancements in novel transplant products and methods by biotechnology and medical device companies, rising healthcare spending, and increasing number of tissue banks.

Restraints: Scarcity of organ donors for transplantation procedures are projected to limit market expansion

  • Some limitations, such as a scarcity of organ donors for transplantation procedures, are projected to limit market expansion.
  • In some nations, financial barriers make transplantation difficult. Transplant examination and testing, organ procurement, transplant surgery, recipient postoperative medical care and immunosuppressive therapy, and donation expenditures are all included in the financial costs.

Scope of the report:

The report on the global organ and tissue transplantation sales market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes

Details

Report Title

Organ and Tissue Transplantation Market – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018 & 2019

Forecast Period

2021–2028

Segmentation

Products (Tissue Products, Preservation Solution, and Immunosuppressive Drugs), by Applications (Organ Transplantation and Tissue Transplantation), End-users (Hospitals, Transplant Centres, and Others)

Regional Scope

Asia Pacific, North America, Europe, Latin America, and Middle East & Africa

Report Coverage

Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast

Key Players Covered

Arthrex, Inc., Zimmer Biomet, Medtronic, Novartis AG, Stryker, BioLife Solutions, and Veloxis Pharmaceuticals, Inc.

 

Global Organ and Tissue Transplantation Sales Market Segment Insights:

Increasing number of tissue transplantation procedures to drive the market

In terms of products, the global organ and tissue transplantation sales market is segmented into tissue products, preservation solution, and immunosuppressive drugs. The tissue products segment accounted for a major share of the market, due to increasing number of transplantation procedures such as heart valves, orthopedic soft tissues, cochlear, and bone marrow. The preservation solution segment is expected to grow by double digits during the forecast period, due to increased prevalence of chronic diseases leading to large number of transplantation procedures, government support for stem cell research and development of advanced products to improve physiological function of organs, and government support for stem cell research and development of advanced products to improve physiological function of organs.


Organ and Tissue Transplantation Market by taxonomy

Large number of tissue replacement procedures to drive the market

Based on applications, the global organ and tissue transplantation sales market is segmented into organ transplantation and tissue transplantation. The tissue transplantation segment dominated the market, due to large number of replacement procedures of cornea, heart valves, nerves, skin, bones, tendons, and veins done worldwide. Increasing number of burn and accident cases is projected to boost the demand for tissue transplantation. The organ transplantation segment is expected to expand at a significant rate in the coming years, owing to increasing number of organ transplants performed globally as well as high demand for immunosuppressants and preservation solutions.

Speedy medical actions in hospitals to drive the market

On the basis of end-users, the global organ and tissue transplantation sales market is segmented into hospitals, transplant centers, and others. The hospitals segment accounted for a large share of the market, owing to the significant number of organ and tissue transplant procedures performed at hospitals, which are the principal treatment centers. Furthermore, the introduction of hospitals with advanced infrastructure, as well as access to databases for verifying organ availability, are assisting in speedy medical actions. The transplant centers segment is expected to expand at a rapid rate over the projection period, due to rising demand for healthcare facilities that cater to unmet requirements of patients and encouragement to organ donation by government programs.

Increasing occurrence of organ failures in North America to drive the market
In terms of regions, the global organ and tissue transplantation sales market is split into North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa. The global organ and tissue transplantation market was dominated by North America, followed by Europe, owing to increasing occurrence of organ failures, sophisticated healthcare infrastructure, medical sector advancements, and rising healthcare expenditure. Most kidney transplants are performed in the US and Europe, where there are many donors and high access to such treatments. Growing research on stem cells to develop in vitro tissue and organs, as well as rising healthcare infrastructure, boost the market in Europe. The frequency of organ donation varies by countries, due to differences in the legislation that allow or prohibit donation. The highest rates of deceased organ donors are found in Spain, Portugal, and the US, a large number of patients is waiting for transplants. Over 108,000 people in the US alone are waiting for organ transplants, the majority of whom need a kidney transplant. The market in Asia Pacific is growing rapidly. Factors such as a large patient population with chronic diseases, organ donation drives and initiatives by national governments and non-governmental organisations in the region, and rapidly expanding medical tourism services combined with low costs of organ transplantation procedures are all driving the market in Asia Pacific.


Organ and Tissue Transplantation Market by regions

Segments

Segments Covered in the Report:

By Products

  • Tissue Products
  • Preservation Solution
  • Immunosuppressive Drugs
By Applications
  • Organ Transplantation
  • Tissue Transplantation
By End-users
  • Hospitals
  • Transplant Centres
  • Others
By Regions
  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa
By Key Players
  • Arthrex, Inc.
  • Zimmer Biomet
  • Medtronic
  • Novartis AG
  • Stryker
  • BioLife Solutions
  • Veloxis Pharmaceuticals, Inc

Competitive Landscape

Major players in the market are Arthrex, Inc., Zimmer Biomet, Medtronic, Novartis AG, Stryker, BioLife Solutions, and Veloxis Pharmaceuticals, Inc. The competitive landscape section includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Organ and Tissue Transplantation Market by key players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Organ and Tissue Transplantation Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Organ and Tissue Transplantation Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Organ and Tissue Transplantation Market - Supply Chain
  4.5. Global Organ and Tissue Transplantation Market Forecast
     4.5.1. Organ and Tissue Transplantation Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Organ and Tissue Transplantation Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Organ and Tissue Transplantation Market Absolute $ Opportunity
5. Global Organ and Tissue Transplantation Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Organ and Tissue Transplantation Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Organ and Tissue Transplantation Demand Share Forecast, 2019-2026
6. North America Organ and Tissue Transplantation Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Organ and Tissue Transplantation Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Organ and Tissue Transplantation Demand Share Forecast, 2019-2026
7. Latin America Organ and Tissue Transplantation Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Organ and Tissue Transplantation Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Organ and Tissue Transplantation Demand Share Forecast, 2019-2026
8. Europe Organ and Tissue Transplantation Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Organ and Tissue Transplantation Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Organ and Tissue Transplantation Demand Share Forecast, 2019-2026
9. Asia Pacific Organ and Tissue Transplantation Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Organ and Tissue Transplantation Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Organ and Tissue Transplantation Demand Share Forecast, 2019-2026
10. Middle East & Africa Organ and Tissue Transplantation Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Organ and Tissue Transplantation Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Organ and Tissue Transplantation Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Organ and Tissue Transplantation Market: Market Share Analysis
  11.2. Organ and Tissue Transplantation Distributors and Customers
  11.3. Organ and Tissue Transplantation Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Arthrex, Inc.
     11.4.2. Zimmer Biomet
     11.4.3. Medtronic
     11.4.4. Novartis AG
     11.4.5. Stryker
     11.4.6. BioLife Solutions
     11.4.7. Veloxis Pharmaceuticals, Inc

Segments Covered in the Report:

By Products

  • Tissue Products
  • Preservation Solution
  • Immunosuppressive Drugs
By Applications
  • Organ Transplantation
  • Tissue Transplantation
By End-users
  • Hospitals
  • Transplant Centres
  • Others
By Regions
  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa
By Key Players
  • Arthrex, Inc.
  • Zimmer Biomet
  • Medtronic
  • Novartis AG
  • Stryker
  • BioLife Solutions
  • Veloxis Pharmaceuticals, Inc

Major players in the market are Arthrex, Inc., Zimmer Biomet, Medtronic, Novartis AG, Stryker, BioLife Solutions, and Veloxis Pharmaceuticals, Inc. The competitive landscape section includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Organ and Tissue Transplantation Market by key players

Buy Report